Ascendis Pharma A (ASND) Change in Intangibles (2020 - 2021)

Ascendis Pharma A (ASND) posted Change in Intangibles of -$639305.1 for Q1 2021, up 44.03% sequentially from -$1.1 million in Q4 2020.

Ascendis Pharma A (ASND) Change in Intangibles (2020 - 2021) Analysis & Trends

Ascendis Pharma A has reported Change in Intangibles for 2 years, with the latest figure at -$639305.1 in Q1 2021.

Quarterly Change in Intangibles changed N/A year-over-year to -$639305.1 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$639305.1 (changed N/A YoY) and the FY2021 annual result came in at -$606304.6, up 69.95% from the prior year.
Change in Intangibles climbed to -$639305.1 in Q1 2021 per ASND's latest filing, from -$1.1 million in the prior quarter.
Over five years, Change in Intangibles peaked at -$494096.7 in Q3 2020 and troughed at -$1.1 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Ascendis Pharma A	15.40 Bn	14.73 Bn	268.20 Mn	-

Download Data